SOURCE: BSR DESCRIPTION:By: Phil Thomson, President, Global Affairs, GSK Undeniably, 2020 has been defined by the global spread of COVID-19 and its devastating impacts. The global pandemic, which has taken over a million lives, has shone a spotlight on the healthcare industry. In this unprecedented moment, BSR is pleased to welcome Phil Thomson, President, Global Affairs at GSK, as a plenary speaker for BSR Conference 2020. Phil has more than two decades of experience at the firm, having joined G
Antimicrobial resistance is a leading global health challengei that requires urgent action to ensure a safer world for everyone, everywhere
Effective surveillance and timely data feedback are critical for infection prevention and control programs, and informing appropriate use of anti-infectives
New partnership in Ghana, Kenya, Malawi and Uganda will provide governments and public health community with critical decision-making information to help address AMR
Collaboration to address product development and scale up challenges posed by current pandemic SOURCE: Novartis DESCRIPTION:BASEL, Switzerland, March 26, 2020/3BL Media/ - Today, Novartis and a consortium of life sciences companies announced an important collaboration to accelerate the development, manufacture and delivery of vaccines, diagnostics, and treatments for COVID-19 in response to the pandemic. The industry brings a range of assets, resources, and expertise needed to identify effective
Novartis announces a five-year commitment to the fight against malaria in conjunction with the 7th Multilateral Initiative on Malaria Conference and the Malaria Summit of the Commonwealth Heads of Government meeting. Further, the company releases new African research on progress and remaining challenges toward the 2030 malaria elimination targets, together with Elimination 8 and the KEMRI-Wellcome Trust program.